Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis
- PMID:32960881
- PMCID: PMC7508369
- DOI: 10.1371/journal.pmed.1003346
Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis
Abstract
Background: There is disagreement about the level of asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We conducted a living systematic review and meta-analysis to address three questions: (1) Amongst people who become infected with SARS-CoV-2, what proportion does not experience symptoms at all during their infection? (2) Amongst people with SARS-CoV-2 infection who are asymptomatic when diagnosed, what proportion will develop symptoms later? (3) What proportion of SARS-CoV-2 transmission is accounted for by people who are either asymptomatic throughout infection or presymptomatic?
Methods and findings: We searched PubMed, Embase, bioRxiv, and medRxiv using a database of SARS-CoV-2 literature that is updated daily, on 25 March 2020, 20 April 2020, and 10 June 2020. Studies of people with SARS-CoV-2 diagnosed by reverse transcriptase PCR (RT-PCR) that documented follow-up and symptom status at the beginning and end of follow-up or modelling studies were included. One reviewer extracted data and a second verified the extraction, with disagreement resolved by discussion or a third reviewer. Risk of bias in empirical studies was assessed with an adapted checklist for case series, and the relevance and credibility of modelling studies were assessed using a published checklist. We included a total of 94 studies. The overall estimate of the proportion of people who become infected with SARS-CoV-2 and remain asymptomatic throughout infection was 20% (95% confidence interval [CI] 17-25) with a prediction interval of 3%-67% in 79 studies that addressed this review question. There was some evidence that biases in the selection of participants influence the estimate. In seven studies of defined populations screened for SARS-CoV-2 and then followed, 31% (95% CI 26%-37%, prediction interval 24%-38%) remained asymptomatic. The proportion of people that is presymptomatic could not be summarised, owing to heterogeneity. The secondary attack rate was lower in contacts of people with asymptomatic infection than those with symptomatic infection (relative risk 0.35, 95% CI 0.10-1.27). Modelling studies fit to data found a higher proportion of all SARS-CoV-2 infections resulting from transmission from presymptomatic individuals than from asymptomatic individuals. Limitations of the review include that most included studies were not designed to estimate the proportion of asymptomatic SARS-CoV-2 infections and were at risk of selection biases; we did not consider the possible impact of false negative RT-PCR results, which would underestimate the proportion of asymptomatic infections; and the database does not include all sources.
Conclusions: The findings of this living systematic review suggest that most people who become infected with SARS-CoV-2 will not remain asymptomatic throughout the course of the infection. The contribution of presymptomatic and asymptomatic infections to overall SARS-CoV-2 transmission means that combination prevention measures, with enhanced hand hygiene, masks, testing tracing, and isolation strategies and social distancing, will continue to be needed.
Conflict of interest statement
I have read the journal's policy and the authors of this manuscript have the following competing interests: GS has participated in two scientific meetings for Merck and Biogen. NL is a member of the PLOS Medicine editorial board.
Figures
Similar articles
- Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: Update of a living systematic review and meta-analysis.Buitrago-Garcia D, Ipekci AM, Heron L, Imeri H, Araujo-Chaveron L, Arevalo-Rodriguez I, Ciapponi A, Cevik M, Hauser A, Alam MI, Meili K, Meyerowitz EA, Prajapati N, Qiu X, Richterman A, Robles-Rodriguez WG, Thapa S, Zhelyazkov I, Salanti G, Low N.Buitrago-Garcia D, et al.PLoS Med. 2022 May 26;19(5):e1003987. doi: 10.1371/journal.pmed.1003987. eCollection 2022 May.PLoS Med. 2022.PMID:35617363Free PMC article.
- Universal screening for SARS-CoV-2 infection: a rapid review.Viswanathan M, Kahwati L, Jahn B, Giger K, Dobrescu AI, Hill C, Klerings I, Meixner J, Persad E, Teufer B, Gartlehner G.Viswanathan M, et al.Cochrane Database Syst Rev. 2020 Sep 15;9(9):CD013718. doi: 10.1002/14651858.CD013718.Cochrane Database Syst Rev. 2020.PMID:33502003Free PMC article.
- Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.Dinnes J, Deeks JJ, Adriano A, Berhane S, Davenport C, Dittrich S, Emperador D, Takwoingi Y, Cunningham J, Beese S, Dretzke J, Ferrante di Ruffano L, Harris IM, Price MJ, Taylor-Phillips S, Hooft L, Leeflang MM, Spijker R, Van den Bruel A; Cochrane COVID-19 Diagnostic Test Accuracy Group.Dinnes J, et al.Cochrane Database Syst Rev. 2020 Aug 26;8(8):CD013705. doi: 10.1002/14651858.CD013705.Cochrane Database Syst Rev. 2020.Update in:Cochrane Database Syst Rev. 2021 Mar 24;3:CD013705. doi: 10.1002/14651858.CD013705.pub2.PMID:32845525Free PMC article.Updated.
- Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.Dinnes J, Sharma P, Berhane S, van Wyk SS, Nyaaba N, Domen J, Taylor M, Cunningham J, Davenport C, Dittrich S, Emperador D, Hooft L, Leeflang MM, McInnes MD, Spijker R, Verbakel JY, Takwoingi Y, Taylor-Phillips S, Van den Bruel A, Deeks JJ; Cochrane COVID-19 Diagnostic Test Accuracy Group.Dinnes J, et al.Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.Cochrane Database Syst Rev. 2022.PMID:35866452Free PMC article.Review.
- Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC.Wiersinga WJ, et al.JAMA. 2020 Aug 25;324(8):782-793. doi: 10.1001/jama.2020.12839.JAMA. 2020.PMID:32648899Review.
Cited by
- Snapshot PCR surveillance for SARS-CoV-2 in hospital staff in England.Brown CS, Clare K, Chand M, Andrews J, Auckland C, Beshir S, Choudhry S, Davies K, Freeman J, Gallini A, Moores R, Patel T, Poznalska G, Rodger A, Roberts S, Rooney C, Wilcox M, Warren S, Ellis J, Gopal R, Dunning J, Zambon M, Hopkins S.Brown CS, et al.J Infect. 2020 Sep;81(3):427-434. doi: 10.1016/j.jinf.2020.06.069. Epub 2020 Jun 30.J Infect. 2020.PMID:32615198Free PMC article.
- Reconstructing the course of the COVID-19 epidemic over 2020 for US states and counties: results of a Bayesian evidence synthesis model.Chitwood MH, Russi M, Gunasekera K, Havumaki J, Klaassen F, Pitzer VE, Salomon JA, Swartwood NA, Warren JL, Weinberger DM, Cohen T, Menzies NA.Chitwood MH, et al.medRxiv [Preprint]. 2021 Jul 22:2020.06.17.20133983. doi: 10.1101/2020.06.17.20133983.medRxiv. 2021.Update in:PLoS Comput Biol. 2022 Aug 30;18(8):e1010465. doi: 10.1371/journal.pcbi.1010465.PMID:33851183Free PMC article.Updated.Preprint.
- Rates of Asymptomatic COVID-19 Infection and Associated Factors in Olmsted County, Minnesota, in the Prevaccination Era.Vachon CM, Norman AD, Prasad K, Jensen D, Schaeferle GM, Vierling KL, Sherden M, Majerus MR, Bews KA, Heinzen EP, Hebl A, Yost KJ, Kennedy RB, Theel ES, Ghosh A, Fries M, Wi CI, Juhn YJ, Sampathkumar P, Morice WG 2nd, Rocca WA, Tande AJ, Cerhan JR, Limper AH, Ting HH, Farrugia G, Carter RE, Finney Rutten LJ, Jacobson RM, St Sauver J.Vachon CM, et al.Mayo Clin Proc Innov Qual Outcomes. 2022 Dec;6(6):605-617. doi: 10.1016/j.mayocpiqo.2022.10.001. Epub 2022 Oct 18.Mayo Clin Proc Innov Qual Outcomes. 2022.PMID:36277251Free PMC article.
- Systemic corticosteroids for the treatment of COVID-19: Equity-related analyses and update on evidence.Wagner C, Griesel M, Mikolajewska A, Metzendorf MI, Fischer AL, Stegemann M, Spagl M, Nair AA, Daniel J, Fichtner F, Skoetz N.Wagner C, et al.Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD014963. doi: 10.1002/14651858.CD014963.pub2.Cochrane Database Syst Rev. 2022.PMID:36385229Free PMC article.Review.
- Geographic and demographic heterogeneity of SARS-CoV-2 diagnostic testing in Illinois, USA, March to December 2020.Holden TM, Richardson RAK, Arevalo P, Duffus WA, Runge M, Whitney E, Wise L, Ezike NO, Patrick S, Cobey S, Gerardin J.Holden TM, et al.BMC Public Health. 2021 Jun 10;21(1):1105. doi: 10.1186/s12889-021-11177-x.BMC Public Health. 2021.PMID:34107947Free PMC article.
References
- World Health Organization. Coronavirus Disease 2019 (Covid-19) Situation Report—73. Geneva: 2020.
Publication types
MeSH terms
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous